| AMD | age-related macular degeneration |
| ATF | activating transcription factor |
| Chop | C/EBP homologous protein |
| COX | cyclooxygenase |
| Cur-BSA-NPs-Gel | curcumin, bovine serum albumin, nanoparticles, gel |
| CUR-CNLC-GEL | curcumin, cationic nanostructured lipid carriers, nanogel |
| DR | diabetes retinopathy |
| eNOS | endothelial nitric oxide synthase |
| ER stress | endoplasmic reticulum stress |
| ERK | extracellular signal-regulated kinases |
| GCLC | glutamate-cysteine ligase catalytic subunit |
| GCLM | glutamate-cysteine ligase modifier subunit |
| GSH | glutathione |
| HIF-1α | hypoxia-inducible factor—1 alpha |
| HO-1 | heme oxygenase-1 |
| IL-1β, IL-6 | Interleukin—1 beta, interleukin—6 |
| IRE1α | Inositol-requiring transmembrane kinase/endoribonuclease 1α |
| Keap1 | kelch-like ECH-associated protein 1 |
| LC3 | microtubule-associated protein 1A/1B-light chain 3 |
| LPO | lipid peroxidation |
| MAPK | mitogen-activated protein kinase |
| MePEG-PCL | methoxypoly (ethylene glycol)-poly(caprolactone) |
| MMP | matrix metalloproteinases |
| MSVI | moderate to severe visual impairment |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NQO1 | NAD(P)H quinone dehydrogenase 1 |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| OHC | octahydrocurcumin |
| P62 | ubiquitin-binding protein p62 |
| PEG | polyethylene glycol |
| PERK | protein kinase RNA-like endoplasmic reticulum kinase |
| PGE2 | prostaglandin E2 |
| PLGA | poly (lactic-co-glycolic acid) |
| ROS | reactive oxygen species |
| RPE | retinal pigment epithelium |
| SIRT1 | sirtuin-1 |
| Smad3 | mothers against decapentaplegic homolog 3 |
| SOD | superoxide dismutase |
| TGF-β1 | transforming growth factor-beta 1 |
| THC | tetrahydrocurcumim |
| TNF-α | tumor necrosis factor alpha |
| UPR | unfolded protein response |
| VEGF | vascular endothelial growth factor |